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Abstract
Background: Primary cardiac sarcomas are extremely rare. Furthermore, the myxofibrosarcomas are one of the
rarest forms of cardiac sarcomas, and its prognosis is known to be quite poor.
Case presentation: This is a case of a 23-year-old man who presented with acute severe congestive heart failure
caused by almost complete obstruction of the mitral valve due to a large left atrial tumor. The patient required
endotracheal intubation before his arrival to the hospital, and underwent an emergent surgical excision of the
tumor. The tumor had a complex shape and originated from the orifice of the right upper pulmonary vein.
Because the tumor seemed to extend over most of the surface of the left atrium, it seemed impossible to
reconstruct the left atrium had we done a complete transmural resection. Instead, we carefully peeled the tumor
leaving the outer layer of the left atrial wall. We applied cryoablation to the attached site, in order to prevent a
recurrence of the tumor. The pathology report revealed that the tumor was a myxofibrosarcoma, and it seemed
to originate from the heart. The patient received radiation therapy after the surgery and continues to be alive
and well after 1-year, without apparent recurrence.
Conclusions: Cardiac myxofibrosarcoma can cause acute, severe left-sided heart failure. Non-transmural atrial wall
resection with cryoablation might be effective for patients with cardiac myxofibrosarcomas with extensive atrial
attachment.
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Background
The majority of cardiac tumors are benign, and approxi-
mately half of them are myxomas [1]. Primary cardiac sar-
comas are rare malignant primary tumors of the heart,
accounting for about 20 % of all primary cardiac tumors
[2]. Myxofibrosarcomas are reported as one of the rarest
forms of cardiac sarcomas [1]. The clinical presentation de-
pends on the site of the tumor and it varies from symptoms
of congestive heart failure to thromboembolism and ar-
rhythmias [3–6]. In this report, we present a 23-year-old
man who presented with symptoms and signs of acute se-
vere left-sided heart failure, requiring an emergent
endotracheal intubation followed by cardiac surgery, caused
by a primary cardiac myxofibrosarcoma in the left atrium.
Case presentation
A 23-year-old man called for an ambulance due to a
sudden onset of severe dyspnea. He had 1-year history
of general malaise without a major change in his weight
or other health problems. At age 13, he had been diag-
nosed with Asperger syndrome for which he received
pharmacological treatment and psychiatric supervision.
Otherwise, he was a healthy young man.
At admission, the patient showed clinical signs of
acute severe left-sided congestive heart failure; a chest x-
ray showed bilateral pleural effusions and a butterfly
shadow. A 2-dimensional echocardiogram revealed that
an intra-atrial tumor occupied the entire left atrial (LA)
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cavity and that it had prolapsed across the mitral valve
without incarceration. The tumor had both solid and
cystic components, and its stalk seemed to be exten-
sively attached to the posterior LA wall. An enhanced
computed tomography (CT) scan of the thorax also re-
vealed a similar picture (Fig. 1).
The patient underwent an emergent open-heart surgery
under cardiopulmonary bypass. The LA was approached
through a right-sided left atriotomy. The tumor occupied
the entire LA cavity and extended to the entry of the right
upper pulmonary vein (PV). Macroscopically, the tumor
had three differentiated bodies with a shared stalk. One
was a thin and fragile tumor widely attached to the poster-
ior LA wall and extended from the entry of the right
upper PV to the edge of the mitral annulus. The others’
stalk originated from this tumor. The second tumor was
cyst-like with a smooth surface and it contained a bloody
liquid with no thrombi. Its wall was very fragile and it was
extracted as small pieces from the LA. We were unable to
measure its length and width in vivo, but the pre and
intra- operative echocardiography revealed that this
balloon-like tumor contracted inside the LA and ex-
panded into the left ventricular lumen through the mitral
valve with each heartbeat (Fig. 2). The third one was a
solid, club-like tumor. Its stalk was about 1 cm, the head
was about 3 cm in diameter, and its length was about
7 cm. This tumor herniated across the mitral valve during
the entire cardiac cycle.
These tumors were grossly resected completely from
the LA wall (Fig. 3). The thin tumor was easily peeled
off from the intima of the LA wall without apparent ad-
hesion between the tumor and the outer layer of the LA
wall except the stalk mentioned above. The stalk, which
was about 2 cm in diameter and attached to the outer
layer of the LA wall, was peeled off leaving the outer
layer. Here, we intentionally avoided resecting all the
layers of the LA wall because the thin tumor seemed to
extend over most of the surface of the LA wall. We felt
we would be unable to reconstruct the LA if we
attempted to completely resect the tumor and the wall.
The rest of the tumors were easily resected with the
common stalk. In order to prevent a recurrence of the
tumor, we applied cryoablation to the attached site.
After the tumor resection, we identified a mitral valve
annular enlargement with severe regurgitation, which
was probably caused by the prolapse of the large tumor
across the valve. We performed a mitral valve annulo-
plasty with a Physio II ring (Edwards Lifesciences Corp.
Fig. 1 Pre-operative CT image. An enhanced CT scan showed lung
congestion and intra-atrial tumor occupying the entire left atrial cavity
Fig. 2 Pre-operative trans-esophageal echocardiogram images. The
mobile tumor contracted inside the left atrium during a systolic phrase
(a) and expanded across the mitral valve (b) into the left ventricular dur-
ing a diastolic phrase (c)
Ujihira et al. Journal of Cardiothoracic Surgery  (2016) 11:95 Page 2 of 5
Irvine, CA, USA) with satisfactory results. The surgery
ended safely without major complications or need for
transfusions.
The traditional histological examination with hematoxylin
and eosin technique revealed a tumor composed of spindle-
shaped cells with a predominantly myxoid background
(Fig. 4). Some tumor cells had round-shapes. Most of
the tumor showed hypo to intermediate cellularity
but focally the tumor contained a hypercellular area.
Mitotic figures were found (4 or less mitoses per 50
high-power fields) and there was no necrosis.
Immunohistochemical tests showed a weak immuno-
reactivity for calponin, and patchy positivity for CD34.
It was negative for CD31, Factor VIII, desmin, myogenin,
MyoD1, h-caldesmon, S-100 protein, CAM5.2 and AE1/
AE3. The tumor cells showed focal myofibroblastic differ-
entiation. Therefore, the final diagnosis was myxofibrosar-
coma. The possibilites of angiosarcoma or leiomyosarcoma
Fig. 3 Macroscopic views of the excised tumor. The tumor had three differentiated bodies. a, A thin and fragile tumor widely attached to the posterior left
arial wall. b, A solid and club-like yellow-white colored tumor with myxoid area. c, A cyst with smooth surface
Fig. 4 Histological images. a, An examination with hematoxylin and eosin technique showed spindle-shaped cells with myxoid background. b, Most
of the tumor cells showed spindle-shaped, but some cells were round in shape. c, Focally a hypercellular lesion was found. d, The tumor cells were
weakly immunnoreactive for calponin
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were ruled-out by the histological and immunohistochemi-
cal features.
The patient was discharged on post-operative day 10
without complications. A magnetic resonance imaging
(MRI) of the brain and an enhanced whole body CT
were negative for metastatic disease.
Upon discharge, the patient was referred to a local
cancer center where he later received radiotherapy for
2 weeks, as adjuvant therapy. His postoperative treat-
ment was completed successfully, and 1-year later he
remains asymptomatic without apparent recurrence. A
transthoracic echocardiogram 14 months after the sur-
gery was normal.
Conclusion
A left atrial sarcoma is an extremely rare cardiac tumor,
generally with poor prognosis [7]. One-quarter of all pri-
mary cardiac tumors are malignant; approximately 95 %
are sarcomas and 5 % are lymphomas. Sarcomas of the
heart usually occur in the 3rd or 5th decade of life, and
are seen with equal frequency in males and females [8].
A myxofibrosarcoma is a tumor of mesenchymal ori-
gin that occurs most commonly in the extremities of
elderly patients [9]. Primary myxofibrosarcomas rarely
arise in the heart, and they may involve any of the four
cardiac chambers, but it most frequently affects the
left atrium [10]. Because the primary myxofibrosar-
coma is capable of local invasion or distant metastasis,
the prognosis of patients has been reported to be very
poor despite surgical resection, radiation therapy, and
chemotherapy [10].
Cardiac tumors have a variable clinical presentation
that includes obstruction to blood flow, embolism and
local invasion, resulting in pericardial effusion, arrhyth-
mias or systemic symptoms [3].
A cardiac sarcoma located in the left atrium can cause
obstruction of the mitral valve and cause symptoms of
mitral stenosis such as dyspnea, cough, hemoptysis, and
fatigue, all of which have been reported previously [4].
When the tumors are suspected to incarcerate in the mi-
tral orifice, they require emergent surgery [11]. To the
best of our knowledge, there are no previous reports of
severe acute congestive heart failure caused by a myxofi-
brosarcoma, requiring an emergent endotracheal intub-
ation and operation.
Sarcomas are aggressive tumors with an average sur-
vival of approximately 11 months. The most important
factor that predicts a better prognosis is the ability to
achieve a complete surgical resection of the tumor. Life
expectancy is nearly twice as long for patients in whom
complete tumor resection is achieved, compared with
patients who undergo incomplete excision [4]. Hence,
surgery is the mainstay of treatment for these lesions,
and to date, the extent to which adjuvant chemotherapy
and radiation therapy are beneficial, remains controver-
sial. Burke et al. [12] reported 75 cases of primary sarco-
mas of the heart with better survival rates in the patients
who received chemotherapy and radiotherapy. Repeat
surgical interventions are reported to be effective, with
the patient maintaining a good quality of life between
surgical events [5].
Complete resection of the malignant tumor is ideal,
however, large tumors with a broad stalk attached to the
atrium could make the reconstruction of the atrial wall
difficult [5]. Unfortunately, our patient had a quite broad
tumor stalk, which extended over most of the left atrial
surface. Because of the severity of his presentation, we
were unable to perform an extensive preoperative exam-
ination or planning. It was also mandatory to finish the
surgery as soon as possible to decrease his surgical
stress. Therefore, we performed a non-transmural atrial
wall resection leaving pericardium, with cryoablation on
its stalk near the right upper pulmonary vein. This oper-
ation might be useful for intimal cardiac tumors only
and should not be performed for tumors arising from
the pericardium including metastasis. Fortunately in this
case, the pathology revealed that the tumor was not a
metastasis, so we decided not to add a secondary surgi-
cal intervention in the acute post-operative phase. Due
to the possibility of incomplete resection of the tumor,
we recommended adjuvant radiation therapy along with
follow-up echocardiograms every 3 months.
In summary, primary cardiac sarcomas are rare malig-
nant tumors of the heart with poor prognosis. Clinical
features depend on the site of the tumor and may in-
clude severe acute left sided heart failure for which
emergent tracheal intubation is necessary. Complete
surgical resection provides the greatest chance for sur-
vival; however, non-transmural atrial wall resection with
cryoablation might be effective for patients with exten-
sive atrial attachment. Careful follow-up is necessary to
detect recurrences.
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